James M Galvin
Overview
Explore the profile of James M Galvin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
2631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caudell J, Torres-Saavedra P, Rosenthal D, Axelrod R, Nguyen-Tan P, Sherman E, et al.
Int J Radiat Oncol Biol Phys
. 2022 Dec;
116(3):533-543.
PMID: 36549347
Purpose: The combination of cisplatin and radiation or cetuximab and radiation improves overall survival of patients with locoregionally advanced head and neck carcinoma. NRG Oncology conducted a phase 3 trial...
2.
Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials
Moran J, Molineu A, Kruse J, Oldham M, Jeraj R, Galvin J, et al.
J Appl Clin Med Phys
. 2018 Jul;
19(5):335-346.
PMID: 29959816
The charge of AAPM Task Group 113 is to provide guidance for the physics aspects of clinical trials to minimize variability in planning and dose delivery for external beam trials...
3.
Monroe J, Boparai K, Xiao Y, Followill D, Galvin J, Klein E, et al.
Pract Radiat Oncol
. 2018 Jun;
8(5):324-331.
PMID: 29907507
Purpose: A survey was created by NRG to assess a medical physicists' percent full time equivalent (FTE) contribution to multi-institutional clinical trials. A 2012 American Society for Radiation Oncology report,...
4.
Chun S, Hu C, Choy H, Komaki R, Timmerman R, Schild S, et al.
J Clin Oncol
. 2016 Dec;
35(1):56-62.
PMID: 28034064
Purpose Although intensity-modulated radiation therapy (IMRT) is increasingly used to treat locally advanced non-small-cell lung cancer (NSCLC), IMRT and three-dimensional conformal external beam radiation therapy (3D-CRT) have not been compared...
5.
Al-Hallaq H, Chmura S, Salama J, Lowenstein J, McNulty S, Galvin J, et al.
Int J Radiat Oncol Biol Phys
. 2016 Nov;
97(1):155-163.
PMID: 27843033
Purpose: The NRG-BR001 trial is the first National Cancer Institute-sponsored trial to treat multiple (range 2-4) extracranial metastases with stereotactic body radiation therapy. Benchmark credentialing is required to ensure adherence...
6.
Al-Hallaq H, Chmura S, Salama J, Winter K, Robinson C, Pisansky T, et al.
Pract Radiat Oncol
. 2016 Jun;
6(6):e291-e298.
PMID: 27345129
Introduction: In 2014, the NRG Oncology Group initiated the first National Cancer Institute-sponsored, phase 1 clinical trial of stereotactic body radiation therapy (SBRT) for the treatment of multiple metastases in...
7.
Bruner D, Hunt D, Michalski J, Bosch W, Galvin J, Amin M, et al.
Cancer
. 2015 Apr;
121(14):2422-30.
PMID: 25847819
Background: The authors analyzed a preliminary report of patient-reported outcomes (PROs) among men who received high-dose radiation therapy (RT) on Radiation Therapy Oncology Group study 0126 (a phase 3 dose-escalation...
8.
Moran J, Dempsey M, Eisbruch A, Fraass B, Galvin J, Ibbott G, et al.
Pract Radiat Oncol
. 2015 Mar;
1(3):190-5.
PMID: 25740119
No abstract available.
9.
Gondi V, Cui Y, Mehta M, Manfredi D, Xiao Y, Galvin J, et al.
Int J Radiat Oncol Biol Phys
. 2015 Jan;
91(3):564-70.
PMID: 25586708
Purpose: RTOG 0933 was a phase II trial of hippocampal avoidance during whole brain radiation therapy for patients with brain metastases. The results demonstrated improvement in short-term memory decline, as...
10.
Cui Y, Chen W, Kong F, Olsen L, Beatty R, Maxim P, et al.
Pract Radiat Oncol
. 2014 Nov;
5(2):e67-75.
PMID: 25413413
Purpose: To quantify variations in target and normal structure contouring and evaluate dosimetric impact of these variations in non-small cell lung cancer (NSCLC) cases. To study whether providing an atlas...